Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
Q1 2026 vs. Q4 2025
How the institutions holding Navidea Biopharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 380 | 0 | −380 (−100.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (2)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Ancora Advisors, LLC | 100 | $0 |
| Front Row Advisors LLC | 280 | $0 |